EditorialPresident Joe Biden, who tested positive for COVID-19 the day before, is pictured on a video screen, right, as he streams into a briefing on declining gas prices with his economic advisers in Washington, July 22, 2022. (Haiyun Jiang/The New York Times)
EditorialDr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, on screen, testifies before the Senate Health Committee in Washington, June 16, 2022. (Haiyun Jiang/The New York Times)
EditorialA patient with pills of Paxlovid, the more powerful of the two COVID-19 antiviral pills approved by the Food and Drug Administration, at her home in Santa Barbara, Calif., Jan. 6, 2021. (Alex Welsh/The New York Times)
EditorialMary Ann Neilsen holds her last Paxlovid pills while recovering from COVID-19 in Santa Barara, Calif., on Jan. 6, 2022. (Alex Welsh/The New York Times)
EditorialMary Ann Neilsen holds her last Paxlovid pills while recovering from COVID-19 in Santa Barara, Calif., on Jan. 6, 2022. (Alex Welsh/The New York Times)
EditorialPatrick Creighton, a sports radio host and diabetic who sought monoclonal antibody treatments after testing positive for COVID, in Katy, Texas, Jan. 5, 2022. (Mark Felix/The New York Times)